000 | 01669 a2200517 4500 | ||
---|---|---|---|
005 | 20250517093927.0 | ||
264 | 0 | _c20180320 | |
008 | 201803s 0 0 eng d | ||
022 | _a2056-676X | ||
024 | 7 |
_a10.1038/nrdp.2016.22 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKleeff, Jorg | |
245 | 0 | 0 |
_aPancreatic cancer. _h[electronic resource] |
260 |
_bNature reviews. Disease primers _c04 2016 |
||
300 |
_a16022 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAnimals, Genetically Modified _ximmunology |
650 | 0 | 4 |
_aBiomarkers, Tumor _xanalysis |
650 | 0 | 4 |
_aDiabetes Mellitus _xetiology |
650 | 0 | 4 |
_aEarly Detection of Cancer _xstandards |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aJaundice _xetiology |
650 | 0 | 4 |
_aMagnetic Resonance Imaging _xmethods |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aModels, Animal |
650 | 0 | 4 |
_aNeoplasm Proteins _xanalysis |
650 | 0 | 4 |
_aPancreatic Neoplasms _xepidemiology |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 |
_aProto-Oncogene Proteins p21(ras) _xanalysis |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 |
_aTomography, X-Ray Computed _xmethods |
650 | 0 | 4 |
_aWeight Loss _ximmunology |
700 | 1 | _aKorc, Murray | |
700 | 1 | _aApte, Minoti | |
700 | 1 | _aLa Vecchia, Carlo | |
700 | 1 | _aJohnson, Colin D | |
700 | 1 | _aBiankin, Andrew V | |
700 | 1 | _aNeale, Rachel E | |
700 | 1 | _aTempero, Margaret | |
700 | 1 | _aTuveson, David A | |
700 | 1 | _aHruban, Ralph H | |
700 | 1 | _aNeoptolemos, John P | |
773 | 0 |
_tNature reviews. Disease primers _gvol. 2 _gp. 16022 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/nrdp.2016.22 _zAvailable from publisher's website |
999 |
_c26000902 _d26000902 |